iPhone | iPad
Android
Huawei
Weinstein is serving a 16-year sentence after being convicted on rape charges by a California court
KT APPDOWNLOAD
Astellas' gastric cancer therapy gets UK regulator's nod
The monoclonal antibody, to be sold under brand name Vyloy, can recognise and attach itself to certain cancer cells to destroy them
Astellas Pharma's logo is pictured at its headquarters in Tokyo, Japan, on December 3, 2019. — Reuters file
Britain's health regulator said on Wednesday it has approved Japan-based Astellas Pharma's therapy to treat a type of gastric cancer.
The monoclonal antibody, to be sold under brand name Vyloy, can recognise and attach itself to certain cancer cells to destroy them.
The regulator approved the therapy in combination with other anti-cancer medicines for adults with stomach or gastro-oesophageal junction cancer.
The gastro-oesophageal junction is where the oesophagus joins the stomach.
In January, the US Food and Drug Administration declined to approve the therapy, citing issues related to a third-party manufacturer.
The company has resubmitted its application, and the US health regulator is set to make its decision by November 9.
More news from World
The company is in talks with other airlines to accommodate its stranded passengers in the event of flight cancellations
The two men were tried in absentia as Pakistan did not force them to appear at the high-security trial as requested by the Netherland
When Sheikh Khaled planted sapling at Rajghat, it was special; here's why
52,000 Gazan children would have started first grade on Monday
Historian Allan Lichtman reveals his much-discussed, once-every-four-years White House prediction, based on what he calls the '13 keys' method
A massive television audience is expected to tune in on Tuesday to watch Harris go toe to toe with Trump over what both are calling the most important election of modern times
This was one of the most violent attacks in years, according to Britain-based Observatory chief Rami Abdel Rahman